Francesco Massari

82PUBLICATIONS
141CO-AUTHORS
Predictive and prognostic markersSurface water quality processes and contaminated sediment assessmentMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (82)

|Oct 12, 2026
Real-World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON-3 Study.

|Oct 04, 2026
Disitamab vedotin in urothelial carcinoma patients: a clinical trial perspective from ARON working group.

|May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments.

|Jan 20, 2026
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features.

Costantino Ricci, Luisa Di Sciascio, Francesca Ambrosi

|Jan 07, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.

Thomas Büttner, Mimma Rizzo, Laura Bernal Vaca

|Oct 29, 2025
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.

Francesco Massari, Matteo Rosellini, Bohuslav Melichar

Pageof 14

Frequent Collaborators

27 joint publications

Veronica Mollica

23 joint publications

Alessandro Rizzo

15 joint publications

Michelangelo Fiorentino

13 joint publications

Alessia Cimadamore